Alyeska Investment Group, L.P. Paratek Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $9.62 Million - $13.1 Million	-943,624 Reduced 66.12%	483,437 $4.93 Million
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $3.63 Million - $5.42 Million	287,349 Added 25.21%	1,427,061 $18.6 Million
Q4 2017 Feb 14, 2018	BUY	$17.45 - $25.6 $3.9 Million - $5.72 Million	223,363 Added 24.38%	1,139,712 $20.4 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $17.3 Million - $25.8 Million	916,349	916,349 $23 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.